These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6796789)

  • 21. Prevalence of high level aminoglycoside and vancomycin resistance among enterococci in Turkey.
    Cirak MY; Sultan N
    Acta Microbiol Pol; 1998; 47(3):267-73. PubMed ID: 9990710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibiotic use in neonatal sepsis.
    Yurdakök M
    Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acquired gentamicin resistance by permeability impairment in Enterococcus faecalis.
    Aslangul E; Massias L; Meulemans A; Chau F; Andremont A; Courvalin P; Fantin B; Ruimy R
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3615-21. PubMed ID: 17065620
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New aspect of the synergistic antibacterial action of ampicillin and gentamicin.
    Barnes AI; Herrero IL; Albesa I
    Int J Antimicrob Agents; 2005 Aug; 26(2):146-51. PubMed ID: 16024233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resistance of six frequently isolated bacteria in intensive care unit patients to some cephalosporins and aminoglycosides.
    Carrington da Costa RB; Costa D; Pimentel J; Conçalves J; Rebelo A; Costa JJ
    J Chemother; 1989 Jul; 1(4 Suppl):323. PubMed ID: 16312421
    [No Abstract]   [Full Text] [Related]  

  • 26. [Infective endocarditis due to high level aminoglycoside resistant Enterococcus faecalis and methicillin resistant coagulase-negative staphylococci presenting with rheumatic manifestations].
    Pişkin N; Akduman D; Aydemir H; Celebi G; Oztoprak N; Aktaş E
    Mikrobiyol Bul; 2008 Jul; 42(3):509-14. PubMed ID: 18822897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Aminoglycoside-resistant enterococci a new bacterial hazard].
    Melhus A
    Lakartidningen; 1999 Apr; 96(14):1694-5. PubMed ID: 10222683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pseudomonas: considerations on its in vitro sensitivity to antibiotics].
    Monaci E
    Quad Sclavo Diagn; 1983 Jun; 19(2):219-22. PubMed ID: 6676772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences in antibiotic resistance patterns of Enterococcus faecalis and Enterococcus faecium strains isolated from farm and pet animals.
    Butaye P; Devriese LA; Haesebrouck F
    Antimicrob Agents Chemother; 2001 May; 45(5):1374-8. PubMed ID: 11302798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The recent aspects of group D Streptococcus sensitivity to antibiotics.
    Turcu T; Mihalcu F; Cuciureanu G; Negurţ E; Stănescu C
    Arch Roum Pathol Exp Microbiol; 1981; 40(3):199-204. PubMed ID: 6800340
    [No Abstract]   [Full Text] [Related]  

  • 31. [Study of "in vitro" susceptibility of "Mycobacterium fortuitum" to aminoglycoside and beta-lactam antibiotics (author's transl)].
    Casal M; Rodriguez F
    Ann Microbiol (Paris); 1981; 132B(1):51-6. PubMed ID: 7305191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Interaction of aminoglycosides and the other antibiotic on selected bacterial strains].
    Grzybowska W; Banaszczyk-Ruś M; Tyski S
    Med Dosw Mikrobiol; 2004; 56(3):275-85. PubMed ID: 15773504
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potentiation of Clostridium botulinum toxin aminoglycoside antibiotics: clinical and laboratory observations.
    Santos JI; Swensen P; Glasgow LA
    Pediatrics; 1981 Jul; 68(1):50-4. PubMed ID: 7243509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antimicrobial drug therapy and microbial sensitivity tests: general concept of antibiotics].
    Miyazakin S; Yamaguchi K
    Rinsho Byori; 1997 Jul; Suppl 105():162-73. PubMed ID: 9379536
    [No Abstract]   [Full Text] [Related]  

  • 35. [Joint action of aminoglycoside antibiotics and nitrofurans with bile on bacteria of the genus Proteus].
    Sytnik IA; Puzakova EV
    Antibiotiki; 1980 Jun; 25(6):437-40. PubMed ID: 7396441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the in vitro activity of new beta-lactams and aminoglycosides against clinical isolates of Pseudomonas aeruginosa.
    Patzer J; Gieburowska R; Dzierzanowska D
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Oct; 253(1):110-20. PubMed ID: 6817544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparison of the antibacterial activity of 5 aminoglycosides and 5 cephalosporins on Proteus and Pseudomonas strains].
    Scioli C; Esposito S; Pennucci C; Galante D; Barba D
    Ann Sclavo; 1982; 24(5):456-65. PubMed ID: 7188242
    [No Abstract]   [Full Text] [Related]  

  • 38. [Comparative study of the antibacterial activity of aminoglycoside antibiotics and their combinations with carbenicillin against Pseudomonas aeruginosa].
    Iakushkina IV; Shapovalova SP; Malkova IV
    Antibiotiki; 1982 Aug; 27(8):601-7. PubMed ID: 6812489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synergistic activity of vancomycin and teicoplanin alone and in combination with streptomycin against Enterococcus faecalis strains with various vancomycin susceptibilities.
    Babalola CP; Patel KB; Nightingale CH; Nicolau DP
    Int J Antimicrob Agents; 2004 Apr; 23(4):343-8. PubMed ID: 15081082
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pattern of antimicrobial susceptibility of enterococci strains].
    Hoyos A; Gutiérrez J; Piédrola G
    Rev Med Chil; 1995 Apr; 123(4):473-8. PubMed ID: 8525192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.